Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with a simple error screen and minimal navigation.SummaryDifference19%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the site's underlying content or scripts. No substantive study information or functionality appears to be changed.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now displays a generic error page (HTTP 500) instead of the study record content, indicating the page is temporarily unavailable.SummaryDifference18%

- Check70 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This indicates a new release of the study record, reflecting a minor update to the page's metadata.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page shows a new revision tag: Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor page revision/update in the site's documentation.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page shows a new Revision: v3.6.2, replacing v3.6.0. This indicates a backend or documentation version update without altering the study details.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.